CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER

Test Usage:

This assay is useful as an aid in monitoring patients with metastatic prostate cancer. The self search system identifies and enumerates the number of circulating tumor cells in blood. This number correlates well with progression and overall survival in patients with metastatic prostate cancer. Patients on Doxorubicin (Adriamycin) must give a gap of minimum 7 days prior to blood sampling.